Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR.
Ren, Shengxiang
Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR. [electronic resource] - International journal of cancer Dec 2014 - 2962-71 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-0215
10.1002/ijc.28925 doi
Aged
Antigens, CD
Biomarkers--metabolism
Cadherins--metabolism
Carcinoma, Non-Small-Cell Lung--drug therapy
Disease Progression
Drug Resistance, Neoplasm
Epithelial-Mesenchymal Transition
Epithelium--pathology
ErbB Receptors--antagonists & inhibitors
Female
Fibronectins--metabolism
Humans
Immunohistochemistry
Lung Neoplasms--drug therapy
Male
Middle Aged
Mutation
Phenotype
Protein Kinase Inhibitors--pharmacology
Retrospective Studies
Treatment Outcome
Vimentin--metabolism
Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR. [electronic resource] - International journal of cancer Dec 2014 - 2962-71 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-0215
10.1002/ijc.28925 doi
Aged
Antigens, CD
Biomarkers--metabolism
Cadherins--metabolism
Carcinoma, Non-Small-Cell Lung--drug therapy
Disease Progression
Drug Resistance, Neoplasm
Epithelial-Mesenchymal Transition
Epithelium--pathology
ErbB Receptors--antagonists & inhibitors
Female
Fibronectins--metabolism
Humans
Immunohistochemistry
Lung Neoplasms--drug therapy
Male
Middle Aged
Mutation
Phenotype
Protein Kinase Inhibitors--pharmacology
Retrospective Studies
Treatment Outcome
Vimentin--metabolism